Home » Topics » BioWorld Science

BioWorld Science
RSS

Theratechnologies submits IND application to Health Canada for ThGRF1-44

Aug. 10, 2001

Final results of PH-10 pilot study in the treatment of plaque psoriasis reported

Aug. 10, 2001

Preliminary animal studies indicate that Oxycyte may be safer than other PFC emulsions

Aug. 10, 2001

Companies form strategic agreement to develop asthma and allergic rhinitis products

Aug. 10, 2001

Dual PPAR agonist shows good preclinical results

Aug. 10, 2001

Incara's porphyrin-based catalytic antioxidant is neuroprotective in ischemia

Aug. 10, 2001

Smooth muscle-relaxing agents reported by Kissei

Aug. 9, 2001

Kyowa Hakko patents new compounds for treatment of urinary incontinence

Aug. 9, 2001

Cyclin-dependent kinase inhibitors identified by Bristol-Myers Squibb

Aug. 9, 2001

BVdU reported to be useful for inhibiting the growth of hyperproliferative cells

Aug. 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...